Home›People›Michelle Arkin
MA

Michelle Arkin

Director at Ambagon Therapeutics.

ExecutiveDirector
Updated Oct 27, 2026·Latest SEC filing Jun 1, 2022·Suggest an edit

About Michelle Arkin

Form D filings for Ambagon Therapeutics from 2020 to 2022 list Michelle Arkin as director.

Michelle Arkin first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Michelle Arkin in the role, so the role may have started earlier or lasted longer.

Ambagon Therapeutics Inc.
Director
2020 – 2022 · Eindhoven, Netherlands
Develops experimental cancer drugs that stabilize interactions between proteins.

Key Colleagues at Startups

The people Michelle Arkin works with at each company, as listed on that company's latest Form D.

Ambagon Therapeutics Inc. · Form D/A, Jun 1, 2022
JS
Josh Seidenfeld
Executive officer
PD
Peter Dudek
Director
RB
NP
Nancy Pryer
Executive officer
Christian Ottmann
Christian Ottmann
Co-Founder & Chief Executive Officer
AR
MM
Melissa McCracken
Partner, Nextech Invest and director
BM
Bryan Miller
Executive officer
SC
Scott Clarke
Chief Executive Officer and director

Sources

  1. SECAmbagon Therapeutics Inc. Form D/A, filed Jun 1, 2022